For FDA Emergency Use Authorization (EUA) Only. For Prescription Use. For In Vitro Diagnostic (IVD) Use.

You've told us at-home testing is extremely important to helping reduce the spread of Coronavirus.1

Here is the product we've created for you.



Designed to provide
test results in 30 minutes

Easy to use

Easy To Use

3 simple steps designed to
take less than 1 minute

Easy to read

Easy to Read Results

Designed with a simple
light up display



Manufactured in
the USA

The Lucira COVID-19 All-In-One Test Kit is the first FDA EUA authorized prescription at-home molecular test for individuals 14 years and older.

1. Swab Your Nose

2. Stir Into Sample Vial

3. Get Results in 30 Minutes

4. Seek Treatment

Our clinical studies show 100% of users 14 and older were able to run our test.¹

¹Lucira Usability Clinical Study 07A-CLI-004/005 conducted Summer 2020 (n=352)

Lucira’s technology has been in development for over 5 years.
The moment for accurate at-home testing is now.

Lucira’s COVID-19 All-In-One Test Kit is a molecular in vitro diagnostic test that has an analytical sensitivity, or ability to detect the SARS-CoV-2 virus, that is comparable to some of the best molecular tests performed in clinical settings and high complexity labs.

In a Community Testing Study, where the Lucira test was compared to a FDA authorized known high sensitivity SARS-CoV-2 test, Lucira achieved a 94% positive percent agreement (PPA) and a 98% negative percent agreement (NPA). Excluding samples with very low levels of virus that possibly no longer reflected active infection1, Lucira achieved 100% positive percent agreement.

1. La Scola B., Clinical Infectious Diseases, September 2020
Lucira Community Testing Study Positive Percent Agreement (PPA) Summary

The above graph shows the Lucira COVID-19 All-In-One Test Kit positive percent agreement in the Community Testing Study. BLUE bars represent samples where the Lucira positive test result matched the comparison test result. GREY bars represent the Lucira test results that were negative and did not match the comparison test positive result. All of the GREY bars occurred in samples where there were very low levels of virus detected by the comparison test.

This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Sign up for product availability updates

Or Request More Info for additional details.

For all media inquiries please contact:
Kevin Knight at 206-451-4823 or media@lucirahealth.com